Annexon scoops up $100m

Annexon Inc, a clinical-stage biopharmaceutical company, has raised $100 million in financing. R

1 July 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Briefs